VIRX BIOLPAR
Last · NASDAQ$1.674+0.024 (+1.45%)live · yahoo · 3h ago
Vol 23.4K ≈ 39.1K
MA10MA20MA50
Market cap$2.25M1.3M sh
P/E · TTM-0.1fwd -0.3 · eps -12.22 · loss
Beta1.39vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.61$21.75
Volume23.4Ksession
Issuer
Legal nameVIRX BIOLPAR
HQUnited States (US)
ListingUS VRAX
ISINKYG9495L1335
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2835
CurrencyUSD
Entity registrysec:0001885827
CIK0001885827
Websitewww.viraxbiolabs.com
Employees19
AddressVirax Biolabs Group Ltd. Bo'Ness Road Newhouse ML1 5UH, Lanarkshire
Loading chart…
OpenFilings analyst
Our analyst
20-F · 2026-07-06
From latest 20-F · 2026-07-06
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -40439.1%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -37204.3%
- Cash Runway Low — Cash runway ~1.4 years
- Accumulated Deficit High — Accumulated deficit / equity 391%
- Rd Intensity High — R&D/Revenue 30092.2%
Documents
FormReporting forFiledFlags
Showing 5 of 40 filings